Product Code: GVR-4-68040-042-7
Handheld X-rays Market Growth & Trends:
The global handheld X-rays market size is expected to reach USD 1.62 billion by 2030, registering a CAGR of 11.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market growth can be attributed rising number of orthopedic surgeries and increasing number of dental problems globally. Hand-held x-rays technologies have played a significant role in the evolution of medical imaging over the past few years. The foundation of healthcare sector is inclusive of diagnostic accuracy, and hand-held x-rays significantly contributes to improving diagnostic accuracy. Moreover, major market participants are also working to develop cutting-edge modalities which can be operated and used for various domains such as cardiology, and orthopedic.
In addition, increasing number of dental surgical procedures globally may further grow the demand for hand-held x-rays. For instance, as per American Dental Association (ADA), over 15 million root canal procedures are performed in the United States each year. Additionally, the National Institute of Dental and Craniofacial Research (NIDCR) reports that approximately 53,000 people in the United States are diagnosed with oral cancer each year and many of these cases require surgical treatment. Therefore, with surge in surgical procedures globally, the usage of hand-held x-rays may increase, which may further drive the hand-held x-rays market growth.
Handheld X-rays Market Report Highlights:
- The hospital segment dominated the market with a share of 47.1% in 2023. This can be attributed to the growing hospital industry, increasing number of orthopedic surgeries, and rising patient pool across all age groups.
- North America handheld X-rays market held the largest share of 34.1% in 2023. This can be attributed to the presence of major service providers and the high volume of surgical procedures conducted in the region.
- The handheld X-rays market in Asia Pacific is estimated to witness the fastest CAGR of 11.6% during the forecast period. The growth can be attributed to growing population, growing medical tourism, increased demand for better imaging devices and supportive government initiatives for improving healthcare infrastructure in the region.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Application
- 1.2.2. End Use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application outlook
- 2.2.2. End use outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Handheld X-rays Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing technological advancements
- 3.2.1.2. Rising number of dental procedures
- 3.2.1.3. Growing orthopedic surgical cases
- 3.2.1.4. Surge in chronic disorders globally
- 3.2.2. Market restraint analysis
- 3.2.2.1. Less penetration in underdeveloped countries
- 3.2.2.2. High cost of devices
- 3.3. Handheld X-rays Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
Chapter 4. Handheld X-rays Market: Application Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Handheld X-rays Application Market Movement Analysis
- 4.3. Global Handheld X-rays Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 4.4. Dental
- 4.4.1. Dental market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Orthopedic
- 4.5.1. Orthopedic market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Others
- 4.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Handheld X-rays Market: End Use Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Handheld X-rays End Use Market Movement Analysis
- 5.3. Global Handheld X-rays Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
- 5.4. Hospitals
- 5.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Outpatient Facilities
- 5.5.1. Outpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Research & Manufacturing
- 5.6.1. Research & manufacturing market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Handheld X-rays Market: Regional Estimates & Trend Analysis By Application, End Use
- 6.1. Regional Market Share Analysis, 2023 & 2030
- 6.2. Regional Market Dashboard
- 6.3. Global Regional Market Snapshot
- 6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 6.5. North America
- 6.5.1. U.S.
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Competitive scenario
- 6.5.1.3. Regulatory framework
- 6.5.1.4. Reimbursement structure
- 6.5.1.5. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. Canada
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Competitive scenario
- 6.5.2.3. Regulatory framework
- 6.5.2.4. Reimbursement structure
- 6.5.2.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. Mexico
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Competitive scenario
- 6.5.3.3. Regulatory framework
- 6.5.3.4. Reimbursement structure
- 6.5.3.5. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Europe
- 6.6.1. UK
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Competitive scenario
- 6.6.1.3. Regulatory framework
- 6.6.1.4. Reimbursement structure
- 6.6.1.5. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Germany
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Competitive scenario
- 6.6.2.3. Regulatory framework
- 6.6.2.4. Reimbursement structure
- 6.6.2.5. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.3. France
- 6.6.3.1. Key country dynamics
- 6.6.3.2. Competitive scenario
- 6.6.3.3. Regulatory framework
- 6.6.3.4. Reimbursement structure
- 6.6.3.5. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.4. Italy
- 6.6.4.1. Key country dynamics
- 6.6.4.2. Competitive scenario
- 6.6.4.3. Regulatory framework
- 6.6.4.4. Reimbursement structure
- 6.6.4.5. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.5. Spain
- 6.6.5.1. Key country dynamics
- 6.6.5.2. Competitive scenario
- 6.6.5.3. Regulatory framework
- 6.6.5.4. Reimbursement structure
- 6.6.5.5. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.6. Norway
- 6.6.6.1. Key country dynamics
- 6.6.6.2. Competitive scenario
- 6.6.6.3. Regulatory framework
- 6.6.6.4. Reimbursement structure
- 6.6.6.5. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.7. Sweden
- 6.6.7.1. Key country dynamics
- 6.6.7.2. Competitive scenario
- 6.6.7.3. Regulatory framework
- 6.6.7.4. Reimbursement structure
- 6.6.7.5. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.8. Denmark
- 6.6.8.1. Key country dynamics
- 6.6.8.2. Competitive scenario
- 6.6.8.3. Regulatory framework
- 6.6.8.4. Reimbursement structure
- 6.6.8.5. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Asia Pacific
- 6.7.1. Japan
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Competitive scenario
- 6.7.1.3. Regulatory framework
- 6.7.1.4. Reimbursement structure
- 6.7.1.5. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. China
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Competitive scenario
- 6.7.2.3. Regulatory framework
- 6.7.2.4. Reimbursement structure
- 6.7.2.5. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. India
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Competitive scenario
- 6.7.3.3. Regulatory framework
- 6.7.3.4. Reimbursement structure
- 6.7.3.5. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Australia
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Competitive scenario
- 6.7.4.3. Regulatory framework
- 6.7.4.4. Reimbursement structure
- 6.7.4.5. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.5. South Korea
- 6.7.5.1. Key country dynamics
- 6.7.5.2. Competitive scenario
- 6.7.5.3. Regulatory framework
- 6.7.5.4. Reimbursement structure
- 6.7.5.5. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.6. Thailand
- 6.7.6.1. Key country dynamics
- 6.7.6.2. Competitive scenario
- 6.7.6.3. Regulatory framework
- 6.7.6.4. Reimbursement structure
- 6.7.6.5. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Latin America
- 6.8.1. Brazil
- 6.8.1.1. Key country dynamics
- 6.8.1.2. Competitive scenario
- 6.8.1.3. Regulatory framework
- 6.8.1.4. Reimbursement structure
- 6.8.1.5. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8.2. Argentina
- 6.8.2.1. Key country dynamics
- 6.8.2.2. Competitive scenario
- 6.8.2.3. Regulatory framework
- 6.8.2.4. Reimbursement structure
- 6.8.2.5. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9. MEA
- 6.9.1. South Africa
- 6.9.1.1. Key country dynamics
- 6.9.1.2. Competitive scenario
- 6.9.1.3. Regulatory framework
- 6.9.1.4. Reimbursement structure
- 6.9.1.5. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.2. Saudi Arabia
- 6.9.2.1. Key country dynamics
- 6.9.2.2. Competitive scenario
- 6.9.2.3. Regulatory framework
- 6.9.2.4. Reimbursement structure
- 6.9.2.5. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.3. UAE
- 6.9.3.1. Key country dynamics
- 6.9.3.2. Competitive scenario
- 6.9.3.3. Regulatory framework
- 6.9.3.4. Reimbursement structure
- 6.9.3.5. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9.4. Kuwait
- 6.9.4.1. Key country dynamics
- 6.9.4.2. Competitive scenario
- 6.9.4.3. Regulatory framework
- 6.9.4.4. Reimbursement structure
- 6.9.4.5. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Key company market share analysis, 2023
- 7.4. Company Position Analysis
- 7.5. Company Categorization (Emerging Players, Innovators and Leaders
- 7.6. Company Profiles
- 7.6.1. Dental Imaging Technologies Corporation
- 7.6.1.1. Company overview
- 7.6.1.2. Financial performance
- 7.6.1.3. Product benchmarking
- 7.6.1.4. Strategic initiatives
- 7.6.2. REMEDI Co.Ltd
- 7.6.2.1. Company overview
- 7.6.2.2. Financial performance
- 7.6.2.3. Product benchmarking
- 7.6.2.4. Strategic initiatives
- 7.6.3. Genoray
- 7.6.3.1. Company overview
- 7.6.3.2. Financial performance
- 7.6.3.3. Product benchmarking
- 7.6.3.4. Strategic initiatives
- 7.6.4. OXOS Medical
- 7.6.4.1. Company overview
- 7.6.4.2. Financial performance
- 7.6.4.3. Product benchmarking
- 7.6.4.4. Strategic initiatives
- 7.6.5. MaxRayCocoon.com
- 7.6.5.1. Company overview
- 7.6.5.2. Financial performance
- 7.6.5.3. Product benchmarking
- 7.6.5.4. Strategic initiatives
- 7.6.6. Digital Doc LLC.
- 7.6.6.1. Company overview
- 7.6.6.2. Financial performance
- 7.6.6.3. Product benchmarking
- 7.6.6.4. Strategic initiatives
- 7.6.7. EVIDENT
- 7.6.7.1. Company overview
- 7.6.7.2. Financial performance
- 7.6.7.3. Product benchmarking
- 7.6.7.4. Strategic initiatives
- 7.6.8. Carestream Dental LLC
- 7.6.8.1. Company overview
- 7.6.8.2. Financial performance
- 7.6.8.3. Product benchmarking
- 7.6.8.4. Strategic initiatives